Figure 2From: Use of immunohistochemical markers can refine prognosis in triple negative breast cancer Survival until breast cancer death by TNP status. Survival at 3 years time was 76.8% in the TNP cases versus 93.5% among non-TNP cases (p < .0001); Survival at 10 years time were, respectively 65.0% and 74.2% (p = .03).Back to article page